ArticleMaterials (Basel, Switzerland)2026
Mechanical Properties and Freeze-Thaw Cycling Degradation of Loess Improved with an Ionic Curing Agent and Cement Composite.
Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
To address the engineering problems of high cement content, high brittleness, and weak frost resistance of cement-improved loess in the seasonal frozen soil area of Northwest China, F1 ion curing agent (F1) and cement composite improved loess (FCIL) were used in this paper. Through unconfined compressive (UC) strength tests, consolidated undrained (CU) triaxial shear tests, and microscopic pore characteristics analysis, the mechanical properties, freeze-thaw cycle deterioration law, and microscopic pore structure of FCIL were studied. The effects of cement content (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.